Skip to main content

Table 1 Characteristics

From: The insoluble excretion of multi-matrix system mesalazine preparations in patients with ulcerative colitis

 

n = 102

Age

41.6 ± 14.7

Sex (male: female)

49: 53

Inflammatory findings (extensive colitis: left-sided colitis: proctosigmoiditis: proctitis)

13: 18: 10: 61

Defecation frequency at the start of treatment

3.91 ± 3.29

Bristol Stool Form Scale score at the start of treatment (≤ 4: 5: ≥ 6)

44: 32: 26

UC disease activity at the start of treatment (mild: moderate: severe)

66: 35: 1

Concomitant drugs (none: proton pump inhibitors: H2 receptor antagonists)

74: 9: 19